引用次数
引用: 2,263
H-指数: 20
I10-指数 : 29
出版物: 90
Ipi/Nivo for Advanced MCC
Sophia Z. Shalhout , Justine V. Cohen , Khalid Garmen , Emily Y Kim
Journal of Cutaneous Oncology
2022
Iconography : Clinical spectrum of cutaneous melanoma morphology
Arthur J Sober , Elena B Hawryluk , Mitalee P Christman , William M Lin
Elsevier Masson
2018
Clinical landscape of oncolytic virus research in 2020.
Nicholas Macedo , David M Miller , Rizwan Haq , Howard L Kaufman
Journal for ImmunoTherapy of Cancer 8 ( 2)
153
2020
Mechanisms of CRLF2 Rearrangement with IGH and P2RY8 in B-Cell Acute Lymphoblastic Leukemia.
David M Miller , Akinori Yoda , Yuka Yoda , David M Weinstock
Blood 114 ( 22) 3243 -3243
1
2009
TdT Expression Is a Marker of Better Survival in Merkel Cell Carcinoma, and Expression of B-Cell Markers Is Associated With Merkel Cell Polyomavirus
Mai P Hoang , Piotr Donizy , Cheng-Lin Wu , Janusz Kopczynski
American Journal of Clinical Pathology 154 ( 1) 38 -47
2
2020
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun , Or-yam Revach , Seth Anderson , Emily A Kessler
Nature 615 ( 7950) 158 -167
1
2023
Therapy with oncolytic viruses: progress and challenges
Sophia Z Shalhout , David M Miller , Kevin S Emerick , Howard L Kaufman
Nature Reviews Clinical Oncology 20 ( 3) 160 -177
2023
Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma
Neil D Gross , David M Miller , Nikhil I Khushalani , Vasu Divi
New England Journal of Medicine 387 ( 17) 1557 -1568
18
2022
Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma
Emily Y Kim , Emily S Ruiz , Mia S DeSimone , Sophia Z Shalhout
JAMA Otolaryngology–Head & Neck Surgery 150 ( 5) 414 -420
2024
A phase 1b/2a study of safety and efficacy of NT-I7 in combination with anti-PD-L1 (atezolizumab) in patients with anti-PD-1/PD-L1 naïve or relapsed/refractory (R/R) high-risk skin cancers: The phase 1b report.
Brian Gastman , Steven Fling , George Ansstas , Pauline Funchain
Journal of Clinical Oncology 40 ( 16_suppl) 9561 -9561
3
2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Ann W Silk , Christopher A Barker , Shailender Bhatia , Kathryn B Bollin
Journal for immunotherapy of cancer 10 ( 7)
13
2022
The merkel cell carcinoma patient registry: from promise to prototype to patient
David M Miller , Sophia Z Shalhout , Farees Saqlain , Vishal A Patel
Journal of Registry Management 49 ( 1) 4 -4
1
2022
Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study
Neil D Gross , David M Miller , Nikhil I Khushalani , Vasu Divi
The Lancet Oncology 24 ( 11) 1196 -1205
8
2023
Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma
David M Miller , Keith T Flaherty , Hensin Tsao
, 33, 2 33 ( 2) 60 -67
31
2014
REDCap-based operational tool to guide care coordination in a multidisciplinary cutaneous oncology clinic
Farees Saqlain , Sophia Z Shalhout , Keith T Flaherty , Kevin S Emerick
JCO Oncology Practice 17 ( 9) 527 -533
1
2021
Immune checkpoint inhibition in Marjolin ulcer: a case series
Sophia Z Shalhout , Howard L Kaufman , Ryan J Sullivan , Donald Lawrence
Journal of Immunotherapy 44 ( 6) 234 -238
3
2021
Leptomeningeal carcinomatosis from a recurrent cutaneous squamous cell carcinoma with perineural invasion in a lung transplant patient
Emily E Granger , Ann W Silk , Nirmal S Sharma , Morgan K Groover
JAAD Case Reports 37 61 -63
2023
Immunotherapy for non-melanoma skin cancer
Sophia Z Shalhout , Kevin S Emerick , Howard L Kaufman , David M Miller
Current Oncology Reports 23 1 -10
63
2021
Immunotherapy for nonmelanoma skin cancer: facts and hopes
Sophia Z Shalhout , Howard L Kaufman , Kevin S Emerick , David M Miller
Clinical Cancer Research 28 ( 11) 2211 -2220
26
2022
A retrospective study of ipilimumab plus nivolumab in anti-PD-L1/PD-1 refractory Merkel cell carcinoma
Sophia Z Shalhout , Kevin S Emerick , Howard L Kaufman , Ann W Silk
Journal of Immunotherapy 45 ( 7) 299 -302
14
2022
Sophia Shalhout, PhD Bobby Reddy Philip Eliades Gary A Silverman Ryan Sullivan James Irving James Whisstock Arthur Sober Elena Hawryluk Richard Young Ching-Ni Njauw Nikolai Klebanov Johannes C. Melms Titus J. Brinker Benjamin Izar Annie J. Kruger RAJ KUMAR Yoda, Akinori Genevieve M. Boland Karthik Kumar